The overall survival (OS) analysis by the Kaplan–Meier method with a log rank test revealed that only CCA patients with a high level of angiopoietin-2 showed a trend of shorter survival times than those with a low angiopoietin-2 level (p = 0.083). The gene discussed is ANGPT2; the disease is cholangiocarcinoma.